These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 8228207

  • 1. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH, Admiraal PJ, Derkx FH, Kleinbloesem C, Man in 't Veld AJ, van Brummelen P, Mulder P, Schalekamp MA.
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J, Wuerzner G, Jensen C, Brunner HR.
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [Abstract] [Full Text] [Related]

  • 3. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 4. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
    Azizi M, Guyene TT, Chatellier G, Wargon M, Ménard J.
    Hypertension; 1997 Feb 15; 29(2):634-40. PubMed ID: 9040450
    [Abstract] [Full Text] [Related]

  • 5. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA.
    J Hypertens; 1992 Aug 15; 10(8):803-12. PubMed ID: 1325513
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
    Inglessis N, Nussberger J, Hagmann M, Hiesse-Provost O, Insuasty J, Reid J, Ménard J, Brunner HR.
    J Cardiovasc Pharmacol; 1995 Jun 15; 25(6):986-93. PubMed ID: 7564346
    [Abstract] [Full Text] [Related]

  • 7. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM, Price DA, Fisher ND, Allan DR, McKnight JA, Williams GH, Hollenberg NK.
    Kidney Int; 1997 Sep 15; 52(3):771-7. PubMed ID: 9291199
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
    McIntyre M, MacFadyen RJ, Meredith PA, Menard J, Brunner HR, Insuasty J, Reid JL.
    J Cardiovasc Pharmacol; 1995 Jun 15; 25(6):994-1000. PubMed ID: 7564347
    [Abstract] [Full Text] [Related]

  • 9. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M, Mizuno K, Hashimoto S, Kunii N, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1985 May 20; 61(5):619-29. PubMed ID: 2991035
    [Abstract] [Full Text] [Related]

  • 10. Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.
    van den Meiracker AH, Admiraal PJ, Man in 't Veld AJ, Derkx FH, Ritsema van Eck HJ, Mulder P, van Brummelen P, Schalekamp MA.
    BMJ; 1990 Jul 28; 301(6745):205-10. PubMed ID: 2203486
    [Abstract] [Full Text] [Related]

  • 11. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May 28; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

  • 12. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Squire IB, MacFayden RJ, Reid JL, Devlin A, Lees KR.
    J Cardiovasc Pharmacol; 1996 May 28; 27(5):657-66. PubMed ID: 8859935
    [Abstract] [Full Text] [Related]

  • 13. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug 28; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 14. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Aug 28; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 15. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson JI.
    Am J Med; 1984 Aug 20; 77(2A):52-60. PubMed ID: 6089557
    [Abstract] [Full Text] [Related]

  • 16. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G.
    Hypertension; 1995 Jan 20; 25(1):37-46. PubMed ID: 7843751
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
    Tikkanen I, Omvik P, Jensen HA.
    J Hypertens; 1995 Nov 20; 13(11):1343-51. PubMed ID: 8984133
    [Abstract] [Full Text] [Related]

  • 18. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D, Grima M, Welsch M, Barthelmebs M, Vasmant D, Imbs J.
    Fundam Clin Pharmacol; 1996 Nov 20; 10(5):474-83. PubMed ID: 8902551
    [Abstract] [Full Text] [Related]

  • 19. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
    Hollenberg NK, Fisher ND, Price DA, Williams GH.
    Am J Hypertens; 2000 May 20; 13(5 Pt 1):498-503. PubMed ID: 10826400
    [Abstract] [Full Text] [Related]

  • 20. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F, Natov S, Martinez F, Lacour B, Hannedouche TP.
    Clin Sci (Lond); 1996 Mar 20; 90(3):205-13. PubMed ID: 8777826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.